EUVIMEDEUVIMED entdecken
Open Access · CC0

Effect of dietary branched chain amino acids on liver related mortality: Results from a large cohort of North American patients with advanced HCV infection

Lei Yu iD, Shirley C Paski, Jennifer Dodge, Kiran Bambha, Scott W Biggins, George N Ioannou

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0284739 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Lei Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, University of Washington, Seattle, Washington, United States of America. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Hepatitis C, Liver Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: Center for Liver Investigation Fostering Discovery.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Branched chain amino acids (BCAA) supplementation may reduce the incidence of liver failure and hepatocellular carcinoma in patients with cirrhosis. We aimed to determine whether long-term dietary intake of BCAA is associated with liver-related mortality in a well-characterized cohort of North American patients with advanced fibrosis or compensated cirrhosis. We performed a retrospective cohort study using extended follow-up data from the Hepatitis C Antiviral Long-term Treatment against Cirrhosis (HALT–C) Trial. The analysis included 656 patients who completed two Food Frequency Questionnaires. The primary exposure was BCAA intake measured in grams (g) per 1000 kilocalories (kcal) of energy intake (range 3.0–34.8 g/1000 kcal). During a median follow-up of 5.0 years, the incidence of liver-related death or transplantation was not significantly different among the four quartiles of BCAA intake before and after adjustment of confounders (AHR 1.02, 95% CI 0.81–1.27, P-value for trend = 0.89). There remains no association when BCAA was modeled as a ratio of BCAA to total protein intake or as absolute BCAA intake. Finally, BCAA intake was not associated with the risk of hepatocellular carcinoma, encephalopathy or clinical hepatic decompensation. We concluded that dietary BCAA intake was not associated with liver-related outcomes in HCV-infected patients with advanced fibrosis or compensated cirrhosis. The precise effect of BCAA in patients with liver disease warrants further study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularHepatitis CLiver NeoplasmsHumansRetrospective StudiesAmino Acids, Branched-ChainLiver CirrhosisHepacivirusNorth America

Substanzen

Amino Acids, Branched-Chain

Autor:innen und Institutionen

  • Division of Gastroenterology, University of Washington, Seattle, Washington, United States of America.
  • Division of Gastroenterology, Cedar Sinai School of Medicine, Los Angeles, California, United States of America.
  • Department of Surgery, Division of Transplant Surgery, University of California San Francisco, San Francisco, California, United States of America.
  • Veterans Affairs Puget Sound Health Care System, Seattle, Washington, United States of America.

ORCID-Profile: Lei Yu

Förderung

  • Center for Liver Investigation Fostering Discovery

Zitieren

APA

Yu, L., Paski, S. C., Dodge, J., Bambha, K., Biggins, S. W., & Ioannou, G. N. (2023). Effect of dietary branched chain amino acids on liver related mortality: Results from a large cohort of North American patients with advanced HCV infection. PLOS ONE. https://doi.org/10.1371/journal.pone.0284739

Vancouver

Yu L, Paski SC, Dodge J, Bambha K, Biggins SW, Ioannou GN. Effect of dietary branched chain amino acids on liver related mortality: Results from a large cohort of North American patients with advanced HCV infection. PLOS ONE. 2023. doi:10.1371/journal.pone.0284739

BibTeX
@article{Yu2023,
  author = {Yu, Lei and Paski, Shirley C and Dodge, Jennifer and Bambha, Kiran and Biggins, Scott W and Ioannou, George N},
  title = {Effect of dietary branched chain amino acids on liver related mortality: Results from a large cohort of North American patients with advanced HCV infection},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0284739}
}
Kostenlos starten →